基于组轨迹模型分析系统性硬化症损伤轨迹
在澳大利亚和加拿大前瞻性注册队列的410例病程<2年的系统性硬化症患者中,采用组轨迹模型识别出5次年度随访内的三种损伤轨迹:低损伤(54.6%)、中损伤(36.2%)和高损伤(10.3%)。基线SCTC-DI评分较高者损伤累积更快,高龄、男性、弥漫型、肌腱摩擦感及CRP升高增加高损伤组几率,白人种族和抗着丝点抗体降低该几率。
要点
- 410例早期系统性硬化症患者中识别出低、中、高三种损伤轨迹,分别占54.6%、36.2%和10.3%。
- 弥漫型(OR 6.7)、肌腱摩擦感(OR 5.4)、男性(OR 2.55)和高龄(OR 1.57)增加高损伤轨迹几率。
- 白人种族(OR 0.31)和抗着丝点抗体(OR 0.24)降低高损伤轨迹几率。
核心结论
- 在合并的早期系统性硬化症队列中识别出三种损伤累积轨迹,若干基线特征增加归属更差轨迹的几率,这些发现可能有助于识别需要早期积极治疗的患者。
研究设计与样本
- 在澳大利亚硬皮病兴趣组和加拿大硬皮病研究组的前瞻性注册队列中纳入病程<2年的系统性硬化症新发病例,采用组轨迹模型分析队列前5次年度随访的SCTC-DI轨迹,共纳入410例患者。
主要发现
- 识别出低损伤(54.6%)、中损伤(36.2%)和高损伤(10.3%)三种轨迹组,损伤累积较快者基线SCTC-DI评分较高。
- 与参照组(低损伤)相比,高龄(OR 1.57 [95%CI 1.18-2.10])、男性(OR 2.55 [95%CI 1.10-5.88])、弥漫型(OR 6.7 [95%CI 2.57-17.48])、肌腱摩擦感(OR 5.4 [95%CI 1.86-15.66])和CRP升高(OR 1.98 [95%CI 1.49-2.63])增加高损伤组几率。
- 白人种族(OR 0.31 [95%CI 0.12-0.75])和抗着丝点抗体(OR 0.24 [95%CI 0.07-0.77])降低高损伤组几率。
关键数值与推荐
- 高损伤组 vs 参照组(低损伤):高龄 OR 1.57(95%CI 1.18-2.10),男性 OR 2.55(95%CI 1.10-5.88),弥漫型 OR 6.7(95%CI 2.57-17.48),肌腱摩擦感 OR 5.4(95%CI 1.86-15.66),CRP升高 OR 1.98(95%CI 1.49-2.63),白人种族 OR 0.31(95%CI 0.12-0.75),抗着丝点抗体 OR 0.24(95%CI 0.07-0.77)。
临床怎么用
- 原文结论指出这些发现可能有助于识别需要早期积极治疗的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive organ damage, which can be measured using the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI). We aimed to identify whether distinct trajectories of damage accrual exist and to determine which variables are associated with different trajectory groups. METHODS: Incident cases of SSc (<2 years) were identified in the Australian Scleroderma Interest Group and Canadian Scleroderma Research Group prospective registries. Group-based trajectory modeling was used to identify SCTC-DI trajectories over the cohort's first 5 annual visits. Baseline variables associated with trajectory membership in a univariate analysis were examined in multivariable models. RESULTS: A total of 410 patients were included. Three trajectory groups were identified: low (54.6%), medium (36.2%), and high (10.3%) damage. Patients with faster damage accrual had higher baseline SCTC-DI scores. Older age (odds ratio [OR] 1.57 [95% confidence interval (95% CI) 1.18-2.10]), male sex (OR 2.55 [95% CI 1.10-5.88]), diffuse disease (OR 6.7 [95% CI 2.57-17.48]), tendon friction rubs (OR 5.4 [95% CI 1.86-15.66]), and elevated C-reactive protein level (OR 1.98 [95% CI 1.49-2.63]) increased the odds of being in the high-damage group versus the reference (low damage), whereas White ethnicity (OR 0.31 [95% CI 0.12-0.75]) and anticentromere antibodies (OR 0.24 [95% CI 0.07-0.77]) decreased the odds. CONCLUSION: We identified 3 trajectories of damage accrual in a combined incident SSc cohort. Several characteristics increased the odds of belonging to worse trajectories. These findings may be helpful in recognizing patients in whom early aggressive treatment is necessary.
引用
- Barbacki A, Baron M, Wang M, et al. Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory Modeling. Arthritis Care Res (Hoboken). 2022. PMID: 35226416. doi:10.1002/acr.24873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。